E-LIB Suche - Ergebnisse für: Leroux-Roels, Isabel

1

Environmental sustainability and antimicrobials: an underes..:

De Waele, Jan J. ; Leroux-Roels, Isabel ; Conway-Morris, Andrew
Intensive Care Medicine. 50 (2024) 3 - p. 453-456 , 2024

Link: https://doi.org/10.1007/..

2

One Health surveillance of colistin-resistant Enterobactera..:

De Koster, Sien ; Xavier, Basil Britto ; Lammens, Christine...
PLOS ONE. 19 (2024) 2 - p. e0298096 , 2024

Link: https://doi.org/10.1371/..

3

Cross-border differences in the prevalence and risk factors..:

Dequeker, Sara ; van Hensbergen, Mitch ; den Heijer, Casper D. J....
BMC Infectious Diseases. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

4

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Pr..:

Ison, Michael G ; Papi, Alberto ; Athan, Eugene...
Clinical Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

5

Epidemiology and molecular typing of multidrug-resistant ba..:

van Kleef-van Koeveringe, Stefanie ; Matheeussen, Veerle ; Schuermans, Annette...
European Journal of Clinical Microbiology & Infectious Diseases. 43 (2023) 1 - p. 187-194 , 2023

Link: https://doi.org/10.1007/..

6

Selective digestive decontamination - Pro:

De Waele, Jan J. ; Leroux-Roels, Isabel ; Depuydt, Pieter
Intensive Care Medicine. 49 (2023) 8 - p. 979-981 , 2023

Link: https://doi.org/10.1007/..

7

Safety and Immunogenicity of a Revaccination With a Respira..:

Leroux-Roels, Isabel ; Van Ranst, Marc ; Vandermeulen, Corinne...
The Journal of Infectious Diseases. 229 (2023) 2 - p. 355-366 , 2023

Link: https://doi.org/10.1093/..

8

Immune responses in healthy adults elicited by a bivalent n..:

Waerlop, Gwenn ; Janssens, Yorick ; Jacobs, Bart...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Human Immunity and Susceptibility to Influenza A(H3) Viruse..:

Vandoorn, Elien ; Stadejek, Wojciech ; Leroux-Roels, Isabel...
Emerging Infectious Diseases. 29 (2023) 1 - p. 98-109 , 2023

Link: https://doi.org/10.3201/..

10

Immunogenicity, safety, and preliminary efficacy evaluation..:

Leroux-Roels, Isabel ; Willems, Paul ; Waerlop, Gwenn...
The Lancet Infectious Diseases. 23 (2023) 12 - p. 1360-1369 , 2023

Link: https://doi.org/10.1016/..

11

1936. Efficacy of One Dose of the Respiratory Syncytial Vir..:

Ison, Michael G ; Papi, Alberto ; Langley, Joanne M...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

12

Sanitary installations and wastewater plumbing as reservoir..:

Hamerlinck, Hannelore ; Aerssens, Annelies ; Boelens, Jerina...
Antimicrobial Resistance & Infection Control. 12 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

13

Safety and Immunogenicity of Respiratory Syncytial Virus Pr..:

Hermida, Nerea ; Ferguson, Murdo ; Leroux-Roels, Isabel...
The Journal of Infectious Diseases. , 2023

Link: https://doi.org/10.1093/..

14

Double-Blind, Placebo-Controlled, Dose-Escalating Study Eva..:

Leroux-Roels, Isabel ; Bruhwyler, Jacques ; Stergiou, Lilli...
Vaccines. 11 (2023) 2 - p. 367 , 2023

Link: https://doi.org/10.3390/..

15

Respiratory Syncytial Virus Disease Burden in Community-Dwe..:

Narejos Pérez, Sílvia ; Ramón Torrell, Josep María ; Põder, Airi...
Open Forum Infectious Diseases. 10 (2023) 4 - p. , 2023

Link: https://doi.org/10.1093/..